ISLAMABAD: The Competition Commission of Pakistan (CCP) Friday approved the acquisition of trademarks for the pharmaceutical ...
GlobalData on MSN11h
Sanofi-backed Agomab raises $89m to advance fibrotic disease treatmentsThe funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...
Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Birkin bag maker Hermes reported on Thursday a hefty rise in third-quarter sales, continuing to outshine rivals hit hard by a ...
French Economy, Finance and Industry Minister Antoine Armand attends a joint press conference on the government's role ...
Leerink Partners analyst David Risinger has maintained their bullish stance on SNYNF stock, giving a Buy rating yesterday. David Risinger has ...
Regeneron spent $5 billion repurchasing shares from Sanofi in May 2020 and $900 million repurchasing global rights to Libtayo in July 2022, yet a windfall from sales of its Covid antibody cocktail as ...
Today, there’s an immunoscience renaissance happening, and Sanofi is pushing medical research in this field forward at a much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback